Thomas Holberg Blicher

Principal scientist Immudex

Seminars

Wednesday 20th May 2026
From Epitope to Therapy – Analytical Tools and Workflows for Selecting the Right TCR
9:30 am
  • Antigen-specific proliferation and activation of T cells
  • TCR discovery, characterization, and cross-reactivity screening
  • Evaluation and QC release testing of engineered T cell products
Thomas Holberg Blicher